Osimertinib in EGFR-Mutated Advanced NSCLC. Reply
- PMID: 32374973
- DOI: 10.1056/NEJMc2001514
Osimertinib in EGFR-Mutated Advanced NSCLC. Reply
Comment on
-
Osimertinib in EGFR-Mutated Advanced NSCLC.N Engl J Med. 2020 May 7;382(19):1863. doi: 10.1056/NEJMc2001514. N Engl J Med. 2020. PMID: 32374970 No abstract available.
-
Osimertinib in EGFR-Mutated Advanced NSCLC.N Engl J Med. 2020 May 7;382(19):1863-1864. doi: 10.1056/NEJMc2001514. N Engl J Med. 2020. PMID: 32374971 No abstract available.
-
Osimertinib in EGFR-Mutated Advanced NSCLC.N Engl J Med. 2020 May 7;382(19):1864. doi: 10.1056/NEJMc2001514. N Engl J Med. 2020. PMID: 32374972 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous